Annual report pursuant to Section 13 and 15(d)

Nature of Operations, Business Activities and Summary of Significant Accounting Policies (Detail Textuals)

v3.8.0.1
Nature of Operations, Business Activities and Summary of Significant Accounting Policies (Detail Textuals) - USD ($)
 1 Months Ended 12 Months Ended
Jan. 19, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Aug. 20, 2015
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Cash and cash equivalents   $ 259,955 $ 64,820 $ 3,221,209  
Restricted cash   4,428 37,500    
Property and equipment, net   $ 1,407 9,584    
Property, plant and equipment, depreciation methods   Straight-line method      
Proceeds from common stock issuance     $ 407,669    
Warrants          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Anti-dilutive excluded from the calculation of diluted loss per common share   11,649,500 11,044,500    
Stock Option          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Anti-dilutive excluded from the calculation of diluted loss per common share   1,130,000 1,142,500    
Series B Preferred Stock          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Number of preferred stock   2,833.55 4,031    
Preferred stock shares convertible into common stock   28,335,500 16,124,000    
Shares issued, price per share (in dollars per share)     $ 0.25   $ 0.80
Series D Preferred Stock          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Number of preferred stock   200      
Preferred stock shares convertible into common stock   2,000,000      
Shares issued, price per share (in dollars per share)   $ 0.10      
Redeemable Convertible Series F Preferred Stock          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Number of preferred stock   2,000      
Preferred stock shares convertible into common stock   20,000,000      
Shares issued, price per share (in dollars per share)   $ 0.10      
Emerald Health Sciences Inc | Securities purchase agreement | Subsequent Event          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Shares issued, price per share (in dollars per share) $ 0.10        
Payments received from convertible bridge loan $ 400,000        
Proceeds from common stock issuance $ 1,500,000